Author

Subhradip Karmakar

All India Institute of Medical Sciences , New Delhi, India - Cited by 17,570 - Hematology - Genomics - Cancer Biology

Biography

Dr. Subhradip Karmakar is currently working at Hematology Department. Subhradip Karmakar is research interests includes Hematology in Cancer Therapy. Subhradip Karmakar serving as an editorial member and reviewer of several international reputed journals. Subhradip Karmakar has successfully completed his Administrative responsibilities. Subhradip Karmakar has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Exploring the role of gut microbiome in colon cancer
I Chattopadhyay, R Dhar, K Pethusamy, A Seethy, T Srivastava, R Sah, ...Applied biochemistry and biotechnology 193, 1780-1799, 2021202
49
2021
Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions–An in-silico study
AA Seethy, S Singh, I Mukherjee, K Pethusamy, K Purkayastha, ...Placenta 103, 141-151, 2021202
23
2021
Oxidative stress-induced impairment of trophoblast function causes preeclampsia through the unfolded protein response pathway
I Mukherjee, R Dhar, S Singh, JB Sharma, TC Nag, AR Mridha, P Jaiswal, ...Scientific Reports 11 (1), 18415, 212
20
2021
Cancer immunotherapy: Recent advances and challenges
R Dhar, A Seethy, S Singh, K Pethusamy, T Srivastava, J Talukdar, ...Journal of Cancer Research and Therapeutics 17 (4), 834-844, 2021202
19
2021
Heat shock proteins and their role in pregnancy: Redefining the function of “Old Rum in a New Bottle”
B Jee, R Dhar, S Singh, S KarmakarFrontiers in Cell and Developmental Biology 9, 648463, 2021202
18
2021
TETology: epigenetic mastermind in action
A Seethy, K Pethusamy, I Chattopadhyay, R Sah, A Chopra, R Dhar, ...Applied Biochemistry and Biotechnology 193, 1701-1726, 2021202
18
2021
Neutralizing antibodies and antibody-dependent enhancement in COVID-19: A perspective
S Ajmeriya, A Kumar, S Karmakar, S Rana, H SinghJournal of the Indian Institute of Science 102 (2), 671-687, 2022202
14
2022
Balancing healthcare and economy amidst the COVID-19 pandemic: An Indian experience
R Dhar, B Jee, S KarmakarRisk Management and Healthcare Policy, 827-833, 2021202
10
2021
The scars of COVID19: Preparing for the collateral damages.
R Dhar, B Jee, K Pethusamy, A Seethy, A Kumar, S KarmakarAsian Journal of Medical Sciences 11 (), 2020202
6
2020
Role of serum MRP8/14 in predicting response to methotrexate in children with juvenile idiopathic arthritis
NK Bagri, S Karmakar, P Haldar, R Lodha, SK KabraJCR: Journal of Clinical Rheumatology 27 (8), e336-e341, 2021202
5
2021
Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma
B Nayak, S Panaiyadiyan, P Singh, S Karmakar, S Kaushal, A SethUrologic Oncology: Seminars and Original Investigations 39 (2), 13. e9-13. e1, 2021202
5
2021
Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
R Dhar, K Pethusamy, B Jee, S KarmakarRisk Management and Healthcare Policy, 479-492, 2021202
3
2021
The metabolic addiction of cancer stem cells
OS Sahoo, K Pethusamy, TP Srivastava, J Talukdar, MS Alqahtani, ...Frontiers in Oncology 1, 95589, 0
2
2022
Neglected tropical disease: Why we need to prioritize them more
R Dhar, A Kumar, S KarmakarAsian Journal of Medical Sciences 13 (10), 1-, 0
2
2022
Loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML
Loss of TET with reduced genomic 5-hmC is associated with adverse-risk AMLK Pethusamy, A Seethy, R Dhar, A Karmakar, S Chaudhary, S Bakhshi, ...Leukemia & Lymphoma 63 (14), 346-343, 0
2
2022
New immune horizons in therapeutics and diagnostic approaches to Preeclampsia
I Mukherjee, S Singh, A Karmakar, N Kashyap, AR Mridha, JB Sharma, ...American Journal of Reproductive Immunology 89 (), e13670, 030
2
2023
Unveiling the omicron B. 1.1. 529: the variant of concern that is rattling the globe
Unveiling the omicron B. .. 529: the variant of concern that is rattling the globeR Dhar, J Talukdar, A Nayek, S Ajmeriya, A Kumar, S KarmakarAsian Journal of Medical Sciences 3 (), 66-68, 2022202
1
2022
Non Government Organizations (NGO)-The gap fillers in oncology care during COVID-19 lockdown in Assam, India
Non Government Organizations (NGO)-The gap fillers in oncology care during COVID-9 lockdown in Assam, IndiaJ Talukdar, A Karmakar, R Dhar, A Kumar, S KarmakarAsian Journal of Medical Sciences 2 (6), 5, 20220
1
2021
Synthetic biology: The new era
S Guha, J Talukdar, A Karmakar, S Goswami, A Kumar, R Dhar, ...Asian Journal of Medical Sciences 3 (4), 20, 2022202
1
2022
Fenofibrate mediated activation of PPARα negatively regulates trophoblast invasion
S Singh, R Dhar, S KarmakarPlacenta 26, 40-49, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=9bGqh_4AAAAJ&hl=en

Cited by
Citations 17570
h-index 18
i10-index 24
Recommended Journals
Open Access Journals